FDANonrulemakingFDA-2016-D-1270

Who commented on this docket

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases

14 organizations filed 15 public comments on Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases, at the Food and Drug Administration. The comment window closed 3682d ago.

Organizations
14
Comments
15
RIN
—
Comment window
closed 3682d ago

Commenters (14)

  • American Association for Cancer Researchtrade assoc.
    1 filing · confidence 85%
  • American Association for Clinical Chemistrytrade assoc.
    1 filing · confidence 85%
  • American Clinical Laboratory Associationtrade assoc.
    1 filing · confidence 85%
  • American Society of Hematologytrade assoc.
    1 filing · confidence 85%
  • American Society of Human Geneticstrade assoc.
    1 filing · confidence 85%
  • Association for Molecular Pathologytrade assoc.
    1 filing · confidence 85%
  • Genentech Incunverified attribution
    1 filing · confidence 70%
  • Leukemia & Lymphoma Societytrade assoc.
    1 filing · confidence 85%
  • Personalized Medicine Coalitiontrade assoc.
    1 filing · confidence 85%
  • Pfizer Inc.unverified attribution
    1 filing · confidence 70%
  • The Coalition for 21st Century Medicinetrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.